As many as 65 children in Uzbekistan died after being given the Indian cough and cold syrup "Doc-1 Max", a representative of the Uzbek Supreme Court said on August 11. Officials in the country have previously only referred to around 20 victims.
A criminal case centred on the deaths caused by the contaminated medicine began on August 11 in Uzbekistan. The court heard that 21 people, all Uzbek citizens apart from one citizen of India, who is the director of Quramax Medikal, were being held in the case.
Charges pressed include tax evasion, the production, manufacture, acquisition, storage, transportation for sale or sale of substandard or falsified medicines or medical products, abuse of office, negligence, forgery and bribery.
In December 2022, the cough syrup Doc-1 Max, produced by Indian company Marion Biotech, was associated with the deaths of at least 20 children in Uzbekistan.
The Indian regulator later cancelled the manufacturing licence of Marion Biotech, which exported the medicines to Uzbekistan, and arrested some of its employees.
Related Articles
Gold and silver continue ascent in Indian markets
Gold and silver prices in India surged, pushing both metals close to their record highs. According to India Bullion and Jewellers Association as cited by state owned DD News, the price of 24-carat ... more
Democratic Senators push Trump to ramp up targeted sanctions on Russian LNG
Calls are mounting by Democratic Senators for US President Donald Trump to increase targeted sanctions on Russia’s LNG sector, Reuters reported on September 21. The Democratic Senators expressed ... more
US sanctions Indian petchem traders over Iran deals
The US Treasury’s Office of Foreign Assets Control (OFAC) has sanctioned six Indian companies for their involvement in trading petrochemicals produced in Iran, according to a report released by ... more